Nuvectis Pharma, Inc. Common Stock — Chart, Price & News (NASDAQ:NVCT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Market Capitalization 231.27 M
Employee 13
Founded 2020
CEO N/A
Website www.nuvectis.com
Headquarter Delaware, United States
FIGI BBG012BCR149
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

231.27 M Market capitalization

News

Nuvectis initiates phase 1b trial combining NXP900 with osimertinib

Nuvectis Pharma stock rating reiterated at Buy by H.C. Wainwright

H.C. Wainwright reiterates Buy rating on Nuvectis Pharma stock at $10 target

Nuvectis Pharma adds former Intra-Cellular exec to board of directors

Nuvectis initiates phase 1b program for cancer drug NXP900

Nuvectis (NVCT) Q2 Loss Widens 43%

Nuvectis Pharma stock price target lowered to $10 at H.C. Wainwright

Nuvectis halts NXP800 development for ovarian cancer, shifts focus

Nuvectis reports positive drug interaction study for cancer drug NXP900

Friday’s Insider Activity: Top Buys and Sells in US Stocks

Nuvectis Pharma: Still Interesting, But Still Too Risky To Jump In

Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference